For a long time, the standard of care in mental and behavioral health has been some combination of pharmaceuticals and talk therapy. But with FDA-cleared, rigorously vetted digital health apps, there's a new piece of the puzzle, and it has the potential to combine the advantages of therapy with the scalability of drugs.
In this episode of HIMSSCast, Big Health CEO Peter Hames joins host Jonah...
111 to build a disease management platform with Bayer
Chinese healthcare platform 111 has expanded its existing partnership with global drug maker Bayer Healthcare Co.
The two companies first entered into a strategic partnership last year in September to market innovative drugs and healthcare products for chronic disease management. A digital platform was also built to provide online pharmacist...
The first technology-enabled remote clinical trial was launched nearly a decade ago, and that field – now generally referred to as "decentralized clinical trials" – has been advancing and gaining traction ever since. But, like so many other remote tools, it's been greatly accelerated by the COVID-19 pandemic.
On today's HIMSSCast, host Jonah Comstock and MobiHealthNews Managing Editor Laura...
Those keeping an eye on the digital therapeutics industry over the last several years likely remember the name Dthera Sciences.
The startup and its CEO Ed Cox became one of the developing space's many standard bearers around 2018. During that timeframe it landed a Breakthrough Device designation from the FDA for its Alzheimer's symptoms treatment, with Cox chairing a handful of industry...
Akili Interactive has published the full data from its STARS-ADHD Adjunctive trial. The data builds upon the company's pivotal study of AKL-T01 (now available as EndeavorRx) and suggests the videogame-like digital therapeutic delivers benefits with or without accompanying stimulant medication, and that they persist up to one month following the treatment.
"These results increase the...
insitro, an artificial intelligence drug discovery startup, has added a $400 million Series C round to its already impressive fundraising haul. The financing is set to close during the first full week of April, according to the company.
Canadian Pension Plan Investment Board led the raise, which also included a laundry list of participants. These names include: Andreessen Horowitz, funds and...
